Skip to content

CFDs are complex financial instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. CFDs are complex financial instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

No results found

View more search results

1 2 3 4 5 6 7 8 9 10
Related search: Market Data
Market Data Type of market
See all Market data search results >

ASX 200 reporting season

What do Beach Energy's losses mean for its future strategy?

Argo Investments and ResMed exceed expectations, while Beach Energy faces impairments, highlighting the varied impacts of market conditions and strategic adjustments on top Australian companies.

ASX Source: Adobe images

(AI video summary)

This video was created on 4 August for IG audiences by ausbiz.

Key financial results 

Beach Energy (ASX:BPT)

Beach Energy reported a net loss of $43.8 million for the year ending 30 June, primarily due to a $474 million non-cash impairment from commodity prices affecting its operations in Western Australia and Victoria. Excluding one-time items, net profit rose 32% to $450.5 million. Sales increased 13% to $2 billion, and production climbed 9%. Beach Energy doubled its final dividend to $0.06 per share.

Argo Investments (ASX:ARG)

Argo Investments reported a net profit of $259.8 million, up from $253 million last year. Revenue increased to $285.8 million, with a 13.3% portfolio return. Argo raised its annual dividend to $0.37 per share, a 7% rise, while earnings per share (EPS) grew to $0.34 cents. Despite geopolitical risks, Argo remains optimistic about its performance and franking balance.

ResMed (ASX:RMD)

ResMed beat fourth-quarter (Q4) forecasts, driven by demand for sleep apnoea devices. The company reported a net profit of US$1.4 billion, a 37% increase, and revenue growth of 10% to US$5.1 billion. For the June quarter, net profit rose 30% to US$380 million. Chief Executive Officer (CEO) Mick Farrell expressed confidence in ongoing sales growth despite the rise of weight-loss drugs. ResMed raised its quarterly dividend by 13% to US$0.60 per share and expanded its share buyback scheme to US$150 million per quarter.

Important to know

This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.

   

Ready to open an IG account?

Start your trading journey now

Open a free demo account Open a live account

Contact

New clients
+971 4559 2108

sales.ae@ig.com

Existing clients
+971 4559 2104

helpdesk.ae@ig.com

Phone lines open

24/7 except Sat 2am - 12pm (GMT+4)

Start a  WhatsApp chat

WhatsApp line open
Monday-Friday
8am-5pm (GMT+4)

Company

IG Group

Careers

Investors

Press

Help

Help centre

Sitemap

Make a complaint

Legal 

Terms and agreements

Privacy

Cookies

Disclaimers

  • CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. Professional Clients can lose more than they deposit.
  • The value of shares and ETFs bought through an IG stock trading account can fall as well as rise, which could mean getting back less than you originally put in. Please ensure you fully understand the risks and take care to manage your exposure.
  • IG does not issue advice, recommendations or opinions in relation to acquiring, holding or disposing of a CFD. IG is not a financial advisor and all services are provided on an execution-only basis. This communication is not an offer or solicitation to enter into a transaction and shall not be construed as such.
  • IG is a trading name of IG Limited a company registered at 2702 & 2703 Level 27, Tower 2, Al Fattan Currency House, DIFC, Dubai, United Arab Emirates. IG is authorised and regulated by the Dubai Financial Services Authority (DFSA) under reference No. F001780.
  • The information on this site is not directed at residents of the United States, Belgium or any particular country outside the UAE and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.